Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Theo who wrote (1061)	2/23/1998 7:16:00 PM
From: Pancho Villa	Read Replies (1) \| Respond to of 1359

To All: >Remember the majority of patients that are on these pills are overweight to obese to begin with and are high risk for cardiac problems. Gee, what are the chances they will already have cardiac problems?!?!? :) No brainer. Sorry to butt in here, I was tracking a poster and came across this conversation on your thread and just had to add my 2 cents. < Theo's post adds significantly to the discussion as a profile check indicates he has been an SI member for a long time with no vested interest on IPIC. Even though his findings are not scientific they do carry some weight in my view of the whole thing. The only problem is that even if IPIC is right, it is going to have a hell of a time in court defending against obese people's cardiac problems being related to Redux. I don't wish such a burden to anyone! Much less to a company the size of IPIC. In a related topic I am surprised to see how strong AHP remains (I am short and a bit under water). I wonder if the jury is already out on AHP being capable of using IPIC as the company taking the blame for the whole thing. After all the liabilities would be much more limited. Recall the barron's piece quoting portions of SEC fillings in which IPIC assumes full responsibility for the product. Pancho PS: After the fact I wish I had waited two weeks before covering my IPIC short to put my short power into AOL! Good luck to you longs. I still see it difficult to have this stock drop further without some material news but unfortunately momentum carries on the way down as well.